No competing interests declared.

We congratulate El‐Boghdadly et al. \[[1](#anae15219-bib-0001){ref-type="ref"}\] for their timely and important study investigating the risk to clinicians of nosocomial infection from performing tracheal intubations in patients with COVID‐19. The primary outcome (which included laboratory‐confirmed SARS‐CoV‐2 infection or the need to self‐isolate due to respiratory symptoms) is pragmatic and reflects the actual impact of absence on the hospital workforce. However, many readers would be more interested in knowing to what extent performing tracheal intubation directly exposes them to the risk of contracting COVID‐19. Our discussions with colleagues suggest that many have inferred a high risk of infection from this study, although the authors did not make this claim.

If the risk of contracting the virus were associated with performing tracheal intubation per se, we would expect to see certain signals in the data, which we did not. Specifically: If the virus was contracted during tracheal intubation, we would expect to see a peak of onset at around 5 days with a significant reduction in new cases after 12 days, consistent with the known incubation period \[[2](#anae15219-bib-0002){ref-type="ref"}\]; however, no such distribution was seen (their Fig. 4),There was no increase in risk associated with the absence of personal protective equipment (PPE) (their Table 2),There was no increase in risk associated with intubating a patient\'s trachea with confirmed COVID‐19 vs. a patient with merely suspected disease (their Table 4), andThere was no association between the number of tracheal intubations performed and the primary outcome (their Supplementary Fig. S1).

Additionally, we would expect to see the infection rate of participants being significantly higher than other clinicians working in similar parts of the hospital. At this stage, there is not a sufficient pool of data against which to make this comparison, but it is possible that the infection rate among participants is no higher than in the general hospital workforce \[[3](#anae15219-bib-0003){ref-type="ref"}\], or indeed a community\'s other essential workers \[[4](#anae15219-bib-0004){ref-type="ref"}\]. While pragmatic from a workforce‐planning perspective, the inclusive nature of the primary outcome also makes comparison with reported rates of community prevalence difficult as healthcare workers have been strongly encouraged to report symptoms, obtain testing and absent themselves from work if sick.

Of the 184 (10.7%) clinicians who met the primary outcome, only 53 (3.1%) had laboratory‐confirmed COVID‐19. Of these, only 26 (1.5%) reported this within 14 days of performing a tracheal intubation, and there was no signal to suggest that participants contracted the virus while performing tracheal intubation. This is despite a mean of three tracheal intubations being performed per participant, and 12% of tracheal intubations being performed without WHO‐standard PPE.

We conclude that it is unlikely a significant proportion of the primary outcome cases were caused by performing tracheal intubation. If any conclusion is to be drawn from this study regarding nosocomial transmission during tracheal intubation, we suggest the results are reassuring that the current approach to airway management in COVID‐19 appears to be safe for clinicians.
